CINEUTRAL

Return on Equity (ROE)

14.3%

Updated 1925h ago

Sector Performance

51th percentile

CI

14.3%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

Return on Equity (ROE) measures how efficiently a company generates profit from every dollar of shareholder equity; a 14.3% ROE means CI earned $0.143 for each $1 of equity.

This is slightly above the sector median of 13.5%, placing CI at the 53rd percentile among peers—essentially middle-of-the-pack. The year-over-year and quarter-over-quarter changes are both unavailable (N/A), so no trend can be assessed from the single data point provided. With a moderately above-average ROE but no trend direction, the metric offers neither clear momentum nor a warning, leaving the investment opportunity neutral in terms of profitability efficiency. This static, middling performance aligns with the overall NEUTRAL verdict, as it neither strengthens a bullish case nor raises a red flag.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about CI?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are CI's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

Advertisement

Master CI's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CI research report

Free account — no credit card

CI

14.3%

Sector Median

13.8%

Sector Avg

31.4%

How CI's Return on Equity (ROE) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.